AXSOME THERAPEUTICS INC filings

All
Holdings
Significant ownership
Insider transactions
Annual reports
Quarterly reports
Events
Shareholder votes
SEC filings by AXSOME THERAPEUTICS INC (ownership)
TypeFiledFilerSubjectShares OwnedPercent Owned
SC 13G/A2024-02-14RTW INVESTMENTS, LPAxsome Therapeutics, Inc.4,489,5969.5%EDGAR
SC 13G/A2024-02-14Fairmount Funds Management LLCAxsome Therapeutics, Inc.2,360,0774.9%EDGAR
SC 13G/A2024-02-13VANGUARD GROUP INCAxsome Therapeutics, Inc.3,696,7667.8%EDGAR
SC 13G/A2024-01-26BlackRock Inc.Axsome Therapeutics, Inc.3,239,7466.8%EDGAR
SC 13G2023-07-07Fairmount Funds Management LLCAxsome Therapeutics, Inc.2,344,9805.0%EDGAR
SC 13G/A2023-02-14Fairmount Funds Management LLCAxsome Therapeutics, Inc.2,011,6474.6%EDGAR
SC 13G/A2023-02-14PFM Health Sciences, LPAxsome Therapeutics, Inc.-3.2%EDGAR
SC 13G/A2023-02-14Venrock Healthcare Capital Partners II, L.P.Axsome Therapeutics, Inc.00.0%EDGAR
SC 13G2023-02-14RTW INVESTMENTS, LPAxsome Therapeutics, Inc.2,980,4826.9%EDGAR
SC 13G/A2023-02-09VANGUARD GROUP INCAxsome Therapeutics, Inc.3,417,6287.9%EDGAR
SC 13G/A2023-02-01BlackRock Inc.Axsome Therapeutics, Inc.2,502,9775.8%EDGAR
SC 13G2022-10-26Fairmount Funds Management LLCAxsome Therapeutics, Inc.2,166,6475.4%EDGAR
SC 13G2022-10-24PFM Health Sciences, LPAxsome Therapeutics, Inc.-5.4%EDGAR
SC 13G/A2022-02-09VANGUARD GROUP INCAxsome Therapeutics, Inc.2,685,6227.1%EDGAR
SC 13G/A2022-02-03BlackRock Inc.Axsome Therapeutics, Inc.2,109,6225.6%EDGAR
SC 13G/A2022-01-18IRIDIAN ASSET MANAGEMENT LLC/CTAxsome Therapeutics, Inc.--EDGAR
SC 13G2021-02-10VANGUARD GROUP INCAxsome Therapeutics, Inc.2,641,0747.1%EDGAR
SC 13G2021-02-04IRIDIAN ASSET MANAGEMENT LLC/CTAxsome Therapeutics, Inc.2,064,1585.5%EDGAR
SC 13G/A2021-01-29BlackRock Inc.Axsome Therapeutics, Inc.2,279,7666.1%EDGAR
SC 13G/A2020-02-14Venrock Healthcare Capital Partners II, L.P.Axsome Therapeutics, Inc.2,333,9756.3%EDGAR
External links